The aim of this study is to compare the prevalence of cardiovascular (CVD)-related comorbidities in patients with ankylosing spondylitis (AS), psoriatic arthritis (PsA) or psoriasis (Ps) in UK primary care against matched cohorts. Matched retrospective cohort study used a primary care consultation database. Three cohorts were constructed using all patients with a Read code diagnosis of AS, PsA or Ps between 1999 and 2009; each cohort was then compared in a 1:4 ratio to a matched cohort. The prevalence of CVD-related comorbidities (hypertension, ischaemic heart disease, hyperlipidaemia and diabetes mellitus) were identified by the first consultation of a comorbid Read code, in those with an inflammatory condition of interest. The prevalence of CVD-related comorbidities was compared between each inflammatory cohort and their matched cohort using Fisher’s exact test. Ninety-four AS, 106 PsA and 290 Ps patients were identified. Compared with matched cohorts, the most prevalent CVD-related comorbidity in patients with AS was hypertension (35 (37.2 %) vs. 96 matched (25.5 %), p = 0.03); this was also the case for PsA (41 (38.7 %) vs. 114 matched (26.9 %), p = 0.02). No differences were seen in the prevalence of other CVD-related comorbidities in those with AS, PsA or Ps compared to their matched cohorts. Our findings provide UK comparisons of CVD-related comorbidities in patients with AS, PsA and Ps alone; specifically, demonstrating increased prevalence of hypertension in AS and PsA cohorts compared to their matched cohorts. This further supports the argument for more evidence in the need for screening and intervention around CVD comorbidities in inflammatory conditions.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000) Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 148:209–214
Gabriel SE (2008) Cardiovascular morbidity and mortality in rheumatoid arthritis. Am J Med 121:S9–S14
Monk HL, Muller S, Mallen CD, Hider SL (2013) Cardiovascular screening in rheumatoid arthritis: a cross-sectional primary care database study. BMC Fam Pract 14:150, -2296-14-150
Sattar N, McCarey DW, Capell H, McInnes IB (2003) Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108:2957–2963
Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34:585–592
Heslinga SC, Van den Oever IA, Van Sijl AM et al (2015) Cardiovascular risk management in patients with active ankylosing spondylitis: a detailed evaluation. BMC Musculoskelet Disord 16:80, -015-0532-3
Gulati AM, Semb AG, Rollefstad S et al (2015) On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord-Trøndelag Health Study. Ann Rheum Dis (in press)
Bremander A, Petersson IF, Bergman S, Englund M (2011) Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res 63:550–556
Brophy S, Cooksey R, Atkinson M et al (2012) No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis—a retrospective cohort study using routine data. Semin Arthritis Rheum 42:140–145
Peters MJL, Visman I, Nielen MMJ et al (2010) Ankylosing spondylitis: a risk factor for myocardial infarction? Ann Rheum Dis 69:579–581
Jamnitski A, Symmons D, Peters MJL, Sattar N, MciInnes I, Nurmohamed MT (2013) Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 72:211–216
Ogdie A, Yu Y, Haynes K et al (2015) Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 74:326–332
Kristensen SL, McInnes IB, Sattar N (2015) Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation? Ann Rheum Dis 74:321–322
Jordan K, Clarke AM, Symmons DP et al (2007) Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases. Br J Gen Pract 57:7–14
Prior JA, Ogollah R, Muller S, Chandratre P, Roddy E, Mallen CD (2015) Gout, anxiety, and depression in primary care: a matched retrospective cohort study. Scand J Rheumatol 44:257–258
Porcheret M, Hughes R, Evans D et al (2004) Data quality of general practice electronic health records: the impact of a program of assessments, feedback, and training. J Am Med Inform Assoc 11:78–86
Roubille C, Richer V, Starnino T et al (2015) Evidence-based recommendations for the management of comorbidities in rheumatoid arthritis, psoriasis, and psoriatic arthritis: expert opinion of the Canadian dermatology-rheumatology comorbidity initiative. J Rheumatol 42:1767–1780
Castañeda S, Martín-Martínez MA, González-Juanatey C et al (2015) Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: baseline data of the CARMA project. Semin Arthritis Rheum 44:618–626
Haque N, Lories RJ, de Vlam K (2016) Comorbidities associated with psoriatic arthritis compared with non-psoriatic spondyloarthritis: a cross-sectional study. J Rheumatol 43:376–382
Ernste FC, Sánchez-Menéndez M, Wilton KM, Crowson CS, Matteson EL, Maradit Kremers H (2015) Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study. Arthritis Care Res 67:1015–1021
Iskandar IY, Ashcroft DM, Warren RB et al (2015) Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register. Br J Dermatol 173:510–518
Armstrong AW, Harskamp CT, Armstrong EJ (2013) The association between psoriasis and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens 31:433–442, discussion 442-3
Han C, Robinson DW, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172
Husni ME (2015) Comorbidities in psoriatic arthritis. Rheum Dis Clin North Am 41:677–698
Yeung H, Takeshita J, Mehta NN et al (2013) Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol 149:1173–1179
I would like to thank the Keele GP Research Partnership and the Informatics team at the Arthritis Research UK Primary Care Centre for providing the CiPCA dataset. CiPCA is funded by the North Staffordshire Primary Care Research Consortium and Keele University Institute for Primary Care and Health Sciences.
Contribution statement: Guarantor of overall study integrity: JAP, RH, CDM and SH. Study concept and design: JAP, RH & SH. Data collection and interpretation: NA, YC and JAP. Statistical analysis NA, YC and JAP. Manuscript preparation: NA, JAP, YC, RH, CDM and SH. Final approval of manuscript: NA, JAP, YC, RH, CDM and SH.
JAP is funded by a Launching Fellowship from the NIHR School for Primary Care Research. CDM is funded by the National Institute for Health Research (NIHR) Collaborations for Leadership in Applied Health Research and Care West Midlands, the NIHR School for Primary Care Research and a NIHR Research Professorship in General Practice (NIHR-RP-2014-04-026). The study sponsors had no role in study design; in the collection, analysis and interpretation of data; in the writing of the report and in the decision to submit the paper for publication. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the NIHR (UK). This paper presents independent research which is part-funded by the CLAHRC West Midlands. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.
Ethics, consent and permissions
The CiPCA dataset (and any subsequent studies) was granted ethical approval by the North Staffordshire Research Ethics Committee.
About this article
Cite this article
Ahmed, N., Prior, J.A., Chen, Y. et al. Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study. Clin Rheumatol 35, 3069–3073 (2016). https://doi.org/10.1007/s10067-016-3362-2
- Ankylosing spondylitis
- Cardiovascular disease
- Primary care
- Psoriatic arthritis